Research highlighted that certain polymorphisms in the genes encoding for NLRP3 inflammasome-related molecules are associated with increased susceptibility to B-cell NHL development and correlate with lymphoma patients’ survival and prognosis. The gene discussed is NLRP3; the disease is lymphoma.